Free Trial
→ Everyone’s watching Nvidia right now. Here’s why I’m excited. (From Timothy Sykes) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HTGMQ
HTG Molecular Diagnostics
$0.00
$0.00
▼
$0.02
N/A2.722,292 shsN/A
OLITW
OmniLit Acquisition
$0.09
$0.06
$0.01
▼
$0.23
N/AN/A14,538 shs323 shs
PRENW
Prenetics Global
$0.03
-9.0%		$0.01
$0.01
▼
$0.06
N/AN/A52,538 shs9,534 shs
SMAPW
SportsMap Tech Acquisition
$0.03
-49.8%		$0.05
$0.02
▼
$0.34
N/AN/A13,707 shs270,440 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover
20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HTGMQ
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%-93.33%
OLITW
OmniLit Acquisition
+8.38%-2.36%+24.21%+71.01%+8.38%
PRENW
Prenetics Global
+27.05%+104.00%+144.52%+243.27%+170.45%
SMAPW
SportsMap Tech Acquisition
-49.83%-69.87%-33.11%-42.23%+62.70%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
OLITW
OmniLit Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
PRENW
Prenetics Global
N/AN/AN/AN/AN/AN/AN/AN/A
SMAPW
SportsMap Tech Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HTGMQ
HTG Molecular Diagnostics
0.00
N/AN/AN/A
OLITW
OmniLit Acquisition
0.00
N/AN/AN/A
PRENW
Prenetics Global
0.00
N/AN/AN/A
SMAPW
SportsMap Tech Acquisition
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HTGMQ
HTG Molecular Diagnostics
$6.37M0.00N/AN/AN/ANaN
OLITW
OmniLit Acquisition
N/AN/AN/AN/AN/AN/A
PRENW
Prenetics Global
$41.52MN/AN/AN/AN/AN/A
SMAPW
SportsMap Tech Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HTGMQ
HTG Molecular Diagnostics
-$21.59MN/A0.00N/AN/AN/AN/AN/AN/A
OLITW
OmniLit Acquisition
N/AN/A0.00∞N/AN/AN/AN/AN/A
PRENW
Prenetics Global
N/AN/A0.00∞N/AN/AN/AN/AN/A
SMAPW
SportsMap Tech Acquisition
N/AN/A0.00∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/AN/A
OLITW
OmniLit Acquisition
N/AN/AN/AN/AN/A
PRENW
Prenetics Global
N/AN/AN/AN/AN/A
SMAPW
SportsMap Tech Acquisition
$0.07232.56%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
HTGMQ
HTG Molecular Diagnostics
N/A
OLITW
OmniLit Acquisition
N/A
PRENW
Prenetics Global
N/A
SMAPW
SportsMap Tech Acquisition
N/A

Insider Ownership

CompanyInsider Ownership
HTGMQ
HTG Molecular Diagnostics
2.60%
OLITW
OmniLit Acquisition
N/A
PRENW
Prenetics Global
N/A
SMAPW
SportsMap Tech Acquisition
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
HTGMQ
HTG Molecular Diagnostics
902.21 million2.16 millionNot Optionable
OLITW
OmniLit Acquisition
3N/AN/ANot Optionable
PRENW
Prenetics Global
1N/AN/ANot Optionable
SMAPW
SportsMap Tech Acquisition
N/AN/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

HTG Molecular Diagnostics NASDAQ:HTGMQ

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

OmniLit Acquisition NASDAQ:OLITW

$0.09 0.00 (0.00%)
As of 06/24/2025

OmniLit Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on transactions with companies and/or assets within the photonics or optics, and related sectors. The company was incorporated in 2021 and is based in Miami Beach, Florida.

Prenetics Global NASDAQ:PRENW

$0.03 0.00 (-8.96%)
As of 03:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

SportsMap Tech Acquisition NASDAQ:SMAPW

$0.03 -0.03 (-49.83%)
As of 06/23/2025

SportsMap Tech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is headquartered in Houston, Texas.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas